Cliff Asness's ACTU Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 127,493 shares of Actuate Therapeutics, Inc. (ACTU) worth $195,064, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in ACTU, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 100,384 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Actuate Therapeutics (ACTU) Holding Value Over Time
Track share changes against reported price movement
Quarterly Actuate Therapeutics (ACTU) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +100,384 | Add 370.30% | 127,493 | $1.53 |
| Q1 2026 | +27,109 | New Buy | 27,109 | $2.74 |
Cliff Asness's Actuate Therapeutics Investment FAQs
Cliff Asness first purchased Actuate Therapeutics, Inc. (ACTU) in Q1 2026, acquiring 27,109 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Actuate Therapeutics, Inc. (ACTU) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to Actuate Therapeutics, Inc. (ACTU) was in Q2 2026, adding 127,493 shares worth $195,064.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 127,493 shares of Actuate Therapeutics, Inc. (ACTU), valued at approximately $195,064.
As of the Q2 2026 filing, Actuate Therapeutics, Inc. (ACTU) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Actuate Therapeutics, Inc. (ACTU) was 127,493 shares, as reported at the end of Q2 2026.